Theoretical Changes in Neonatal Hospitalisation Costs After the Introduction of Porcine-Derived Lung Surfactant (‘Curosurf’)

This publication has 25 references indexed in Scilit:

• Porcine surfactant replacement therapy in newborns of 25‐31 weeks’gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses
  Acta Paediatrica, 1995
• Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: Impact on hospital resource use and charges
  The Journal of Pediatrics, 1995
• Porcine-Derived Lung Surfactant
  Drugs, 1994
• Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial).
  Archives of Disease in Childhood, 1993
• Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
  1992
• Cost implications of different approaches to the prevention of respiratory distress syndrome.
  Archives of Disease in Childhood, 1991
• A Comparison of Surfactant as Immediate Prophylaxis and as Rescue Therapy in Newborns of Less Than 30 Weeks' Gestation
  New England Journal of Medicine, 1991
• The use of baselines in clinical trials of bronchodilators
  Statistics in Medicine, 1989
• Surfactant Replacement Therapy: Impact on Hospital Charges for Premature Infants With Respiratory Distress Syndrome
  Pediatrics, 1989
• Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
  1988